Soyama H, Miyamoto M, Matsuura H, Iwahashi H, et al. Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine. Cancer Chemother Pharmacol 2020 Apr 11. pii: 10.1007/s00280-020-04070.
PMID: 32279102